IBI363 + CHEMOTHERAPY

Clinical trials for IBI363 + CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new IBI363 + CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for IBI363 + CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to shrink tumors before stomach cancer surgery

Disease control Recruiting now

This study is testing whether adding an experimental drug called IBI363 to standard chemotherapy helps people with a specific type of locally advanced stomach cancer. The goal is to shrink the tumor before surgery and control the disease afterward. The study will enroll 60 adults…

Matched conditions: IBI363 + CHEMOTHERAPY

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

IBI363 + CHEMOTHERAPY

Get alerted when new IBI363 + CHEMOTHERAPY trials appear

New combo therapy aims to shrink tumors before stomach cancer surgery